Geode Capital Management’s Trinity Biotech TRIB Stock Holding History

Geode Capital Management’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.9K	Sell	420 -135	-24%	-$2.5K	﹤0.01%	4443
2026 Q1	$9.02K	Hold	555	–	–	﹤0.01%	4493
2025 Q4	$13.2K	Hold	555	–	–	﹤0.01%	4419
2025 Q3	$17.3K	Hold	555	–	–	﹤0.01%	4428
2025 Q2	$11K	Hold	555	–	–	﹤0.01%	4414
2025 Q1	$9.48K	Sell	555 -34	-6%	-$805	﹤0.01%	4434
2024 Q4	$15.6K	Buy	+589	New	+$23.6K	﹤0.01%	4404
2021 Q3	–	Sell	-93	Closed	-$40K	–	4872
2021 Q2	$40K	Hold	93	–	–	﹤0.01%	4678
2021 Q1	$52K	Hold	93	–	–	﹤0.01%	4399
2020 Q4	$52K	Hold	93	–	–	﹤0.01%	4164
2020 Q3	$27K	Hold	93	–	–	﹤0.01%	4099
2020 Q2	$30K	Hold	93	–	–	﹤0.01%	4046
2020 Q1	$15K	Hold	93	–	–	﹤0.01%	4057
2019 Q4	$14K	Hold	93	–	–	﹤0.01%	4180
2019 Q3	$16K	Hold	93	–	–	﹤0.01%	4162
2019 Q2	$25K	Hold	93	–	–	﹤0.01%	4148
2019 Q1	$39K	Hold	93	–	–	﹤0.01%	4051
2018 Q4	$31K	Hold	93	–	–	﹤0.01%	4056
2018 Q3	$55K	Hold	93	–	–	﹤0.01%	4021
2018 Q2	$69K	Buy	+93	New	+$67.1K	﹤0.01%	3939
2017 Q2	–	Sell	-160	Closed	-$142K	–	4110
2017 Q1	$142K	Sell	160 -81	-34%	-$76K	﹤0.01%	3749
2016 Q4	$249K	Buy	241 +168	+230%	+$174K	﹤0.01%	3540
2016 Q3	$144K	Hold	73	–	–	﹤0.01%	3705
2016 Q2	$123K	Hold	73	–	–	﹤0.01%	3737
2016 Q1	$126K	Sell	73 -4	-5%	-$6.37K	﹤0.01%	3771
2015 Q4	$135K	Buy	+77	New	+$136K	﹤0.01%	3804

Other funds holding TRIB

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return

Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

MAWA

Moss Adams Wealth Advisors Seattle, Washington $1.6B AUM 28.24% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

BCM

Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Geode Capital Management's TRIB Position: Q2 2026 in Review

Geode Capital Management reduced its Trinity Biotech (TRIB) stake by 24% in Q2 2026, selling an estimated $2.5K and leaving 420 shares worth $4.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4443.

Geode Capital Management first reported a position in TRIB in Q4 2015 and has held it in 26 quarters since. The position peaked at $249K in Q4 2016. 19 funds tracked by Wall St. Rank hold TRIB as of Q2 2026.

Geode Capital Management held 420 shares of Trinity Biotech worth $4.9K as of Q2 2026.
Geode Capital Management sold 135 Trinity Biotech shares in Q2 2026, an estimated $2.5K.
Trinity Biotech made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4443 holding.
Geode Capital Management first reported a position in Trinity Biotech in Q4 2015 and has held it in 26 quarters since.
Geode Capital Management's Trinity Biotech position peaked at $249K in Q4 2016.
19 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.